XPRO—56

Xpro India Ltd

Commodity ChemicalsVerified

Xpro India Ltd has a debt-to-equity ratio of 0.44 and a current ratio of 3.36, indicating a relatively strong liquidity position with sufficient current assets to cover current liabilities. However, the company reported a negative net cash position after subtracting total debt, which raises concerns about its liquidity risk. The company's profitability metrics show a return on equity (ROE) of 6.23% and a return on assets (ROA) of 3.83%, which are below the typical thresholds for high-performing chemical firms. These figures suggest that the company is generating modest returns relative to its equity and asset base. Xpro India's revenue is primarily derived from the production and sale of polymer-based products, including dielectric films and coextruded plastic sheets. The company's geographic exposure is concentrated in India, and it does not disclose significant revenue from international markets. There is no detailed breakdown of revenue by business segment in the provided data. The company's growth trajectory appears mixed. While it reported revenue of INR 5.35 billion in the latest period, the free cash flow was negative at INR 2.43 billion, and capital expenditures were INR 2.87 billion. These figures suggest that the company is investing heavily in its operations, which could support future growth but may also strain liquidity in the short term. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's capital structure includes long-term debt of INR 2.69 billion, and the negative net cash position after debt is a key flag. The dilution risk is low, and there is no indication of near-term pressure from share issuance or other dilutive events. Recent financial filings and transcripts do not provide specific details on new product launches, strategic partnerships, or regulatory changes that could significantly impact the company's operations. The company's focus remains on polymer processing and specialty films, with no major shifts in business strategy disclosed in the available data.

30-day price · XPRO+46.20 (+4.4%)

Low$999.20High$1215.00Close$1084.90As of17 May, 00:00 UTC

Profile

CompanyXpro India Ltd

TickerXPRO.NS

SectorBasic Materials

BusinessChemicals

Industry groupChemicals

IndustryCommodity Chemicals

AI analysis

Business. Xpro India Ltd is a diversified polymer processing company that produces coextruded plastic sheets, thermoformed liners, and specialty films, including dielectric films and BOPP films, primarily for capacitor and energy storage applications.

Classification. Xpro India Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92.

Key takeaways

Xpro India Ltd has a strong current ratio but a negative net cash position after debt, indicating potential liquidity constraints.
The company's ROE and ROA are below industry benchmarks, suggesting limited profitability relative to its equity and asset base.
The company is investing heavily in capital expenditures, which may support long-term growth but could strain short-term liquidity.
The risk assessment indicates a medium liquidity risk and a low dilution risk, with no immediate pressure from share issuance.
Xpro India's revenue is concentrated in India, and there is no detailed segment breakdown provided in the available data.
--
# RATIONALES
```json

Financial snapshot

PeriodHA-latest

CurrencyINR

Revenue$5.35B

Gross profit$1.41B

Operating income$392.0M

Net income$380.0M

R&D—

SG&A—

D&A—

SBC—

Operating cash flow$127.5M

CapEx-$2.87B

Free cash flow-$2.43B

Total assets$9.93B

Total liabilities$3.82B

Total equity$6.10B

Cash & equivalents—

Long-term debt$2.69B

Annual history (last 5)

PeriodRevenueOp IncomeNet IncomeFCF

FY0————

FY-1————

FY-2————

FY-3————

FY-4————

PeriodGross %Op %Net %FCF %

FY0————

FY-1————

FY-2————

FY-3————

FY-4————

PeriodAssetsEquityCashDebt

FY0————

FY-1————

FY-2————

FY-3————

FY-4————

PeriodOCFCapExFCFSBC

FY0————

FY-1————

FY-2————

FY-3————

FY-4————

Quarterly history (last 4)

PeriodRevenueOp IncomeNet IncomeFCF

FQ0————

FQ-1————

FQ-2————

FQ-3————

FQ-4————

FQ-5————

FQ-6————

FQ-7————

PeriodGross %Op %Net %FCF %

FQ0————

FQ-1————

FQ-2————

FQ-3————

FQ-4————

FQ-5————

FQ-6————

FQ-7————

PeriodAssetsEquityCashDebt

FQ0————

FQ-1————

FQ-2————

FQ-3————

FQ-4————

FQ-5————

FQ-6————

FQ-7————

PeriodOCFCapExFCFSBC

FQ0————

FQ-1————

FQ-2————

FQ-3————

FQ-4————

FQ-5————

FQ-6————

FQ-7————

Valuation

Market price—

Market cap—

Enterprise value—

P/E—

Reported non-GAAP P/E—

EV/Revenue—

EV/Op income—

EV/OCF—

P/B—

P/Tangible book—

Tangible book$6.10B

Net cash-$2.69B

Current ratio3.4

Debt/Equity0.4

ROA3.8%

ROE6.2%

Cash conversion34.0%

CapEx/Revenue-53.7%

SBC/Revenue—

Asset intensity—

Dilution ratio0.0%

Risk assessment

Dilution riskLow

Liquidity riskMedium

Net cash is negative after subtracting total debt.

Industry benchmarks

Activity: Chemicals · cohort 11 companies

MetricXPROActivity

Op margin7.3%0.4% medp25 -8.0% · p75 16.0%above median

Net margin7.1%2.3% medp25 -11.6% · p75 11.8%above median

Gross margin26.3%20.8% medp25 14.9% · p75 24.0%top quartile

R&D / revenue—1.1% medp25 0.5% · p75 1.3%

CapEx / revenue-53.7%6.2% medp25 5.4% · p75 10.2%bottom quartile

Debt / equity44.0%59.0% medp25 54.9% · p75 72.9%bottom quartile

Source data

Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.

Company fundamentalsperiod FQ-7 · history via verified-market-data

no public URL

2026-05-04 20:00 UTC#628e63dd

Source: analysis-pipeline (hybrid)Generated: 2026-05-04 20:01 UTCJob: 26672e02